Related references
Note: Only part of the references are listed.Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions
Marc Arbyn et al.
ANNALS OF INTERNAL MEDICINE (2017)
Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18
Long Fu Xi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Use of Cytology, E6/E7 mRNA and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening
Daniela Gustinucci et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management
Philip E. Castle et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Alejandra Castanon et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A cohort study of cervical screening using partial HPV typing and cytology triage
Mark Schiffman et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large US screening population: Data from the ATHENA trial
Joseph Monsonego et al.
GYNECOLOGIC ONCOLOGY (2015)
Development of a cervical cancer progress prediction tool for human papillomavirus-positive Koreans: A support vector machine-based approach
Jimin Kahng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
Christine Bergeron et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
Christine Bergeron et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
Vitaly Smelov et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence
Francesca Carozzi et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix
Astrid Baalbergen et al.
GYNECOLOGIC ONCOLOGY (2013)
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Wiebren A. Tjalma et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Clinical Impact of the Analytical Specificity of the Hybrid Capture 2 Test: Data from the New Technologies for Cervical Cancer (NTCC) Study
Anna Gillio-Tos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
Unnop Jaisamrarn et al.
PLOS ONE (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
Debbie Saslow et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
HPV16 and HPV18 genotyping in cervical cancer screening
Guglielmo Ronco et al.
LANCET ONCOLOGY (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
The Reproducibility of CIN Diagnoses Among Different Pathologists Data From Histology Reviews From a Multicenter Randomized Study
Paolo Dalla Palma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Screening and adenocarcinoma of the cervix
Peter Sasieni et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening
Paolo Dalla Palma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
Guglielmo Ronco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2008)
Members of the human papillornavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix
Gary Clifford et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Women's experiences of repeated HPV testing in the context of cervical cancer screening: A qualitative study
Jo Waller et al.
PSYCHO-ONCOLOGY (2007)
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2006)
Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial
Guglielmo Ronco et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
X Castellsagué et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A study of the impact of adding HPV types to cervical cancer screening and triage tests
M Schiffman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
GP5+/6+PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes
AJC van den Brule et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
